Top News
Pfizer’s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock.
The Covid-19 pill is here, and it couldn’t have come at a better time.
The pandemic grew darker over the past two weeks, as the Omicron variant swept into the U.S. With most of the widely used therapies rendered useless by the variant’s mutations, and case counts quickly climbing, doctors and public health officials have been increasingly worried.
The…
